These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23762716)

  • 1. A Case Report of Congenital Fiber Type Disproportion with an Increased Level of Anti-ACh Receptor Antibodies.
    Kimura S; Ozasa S; Nomura K; Kosuge H; Yoshioka K
    Case Rep Pediatr; 2013; 2013():607678. PubMed ID: 23762716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical characteristics between congenital fiber type disproportion myopathy and congenital myopathy with type 1 fiber predominance.
    Na SJ; Kim WK; Kim TS; Kang SW; Lee EY; Choi YC
    Yonsei Med J; 2006 Aug; 47(4):513-8. PubMed ID: 16941741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion.
    Lawlor MW; Dechene ET; Roumm E; Geggel AS; Moghadaszadeh B; Beggs AH
    Hum Mutat; 2010 Feb; 31(2):176-83. PubMed ID: 19953533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital fiber type disproportion myopathy caused by LMNA mutations.
    Kajino S; Ishihara K; Goto K; Ishigaki K; Noguchi S; Nonaka I; Osawa M; Nishino I; Hayashi YK
    J Neurol Sci; 2014 May; 340(1-2):94-8. PubMed ID: 24642510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent.
    Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA
    Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital fiber type disproportion.
    Kissiedu J; Prayson RA
    J Clin Neurosci; 2016 Apr; 26():136-7. PubMed ID: 26526626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Krabbe leukodystrophy and congenital fiber type disproportion.
    Marjanović B; Cvetković D; Dozić S; Todorović S; Djurić M
    Pediatr Neurol; 1996 Jul; 15(1):79-82. PubMed ID: 8858709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of acetylcholine receptor loss from the neuromuscular junction.
    Engel AG; Fumagalli G
    Ciba Found Symp; 1982; (90):197-224. PubMed ID: 6923808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital fiber type disproportion: report of one case.
    Chang JF; Jong YJ; Mak SC; Chiang CH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1990; 31(6):366-72. PubMed ID: 2284944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
    Lindstrom JM; Einarson BL; Lennon VA; Seybold ME
    J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle fiber type disproportion with an autosomal dominant inheritance.
    Kim WK; Choi BO; Cheon HY; Sunwoo IN; Kim TS
    Yonsei Med J; 2000 Apr; 41(2):281-4. PubMed ID: 10817032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital fiber type disproportion--30 years on.
    Clarke NF; North KN
    J Neuropathol Exp Neurol; 2003 Oct; 62(10):977-89. PubMed ID: 14575234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
    Vincent A; Leite MI
    Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital fiber-type disproportion presenting with type II respiratory failure after delivery: A case report.
    Yang HM; Guo JX; Yang YM
    World J Clin Cases; 2021 Mar; 9(7):1748-1754. PubMed ID: 33728321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in TPM3 are a common cause of congenital fiber type disproportion.
    Clarke NF; Kolski H; Dye DE; Lim E; Smith RL; Patel R; Fahey MC; Bellance R; Romero NB; Johnson ES; Labarre-Vila A; Monnier N; Laing NG; North KN
    Ann Neurol; 2008 Mar; 63(3):329-37. PubMed ID: 18300303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis.
    Howard FM; Lennon VA; Finley J; Matsumoto J; Elveback LR
    Ann N Y Acad Sci; 1987; 505():526-38. PubMed ID: 3479935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital fiber type disproportion: a rare type of congenital myopathy: a report of four cases.
    Sharma MC; Ralte AM; Atri SK; Gulati S; Kalra V; Sarkar C
    Neurol India; 2004 Jun; 52(2):254-6. PubMed ID: 15269486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.